Does Vernal Keratoconjunctivitis Go Away After Puberty?
At a Glance
Yes, about 85% of children outgrow vernal keratoconjunctivitis (VKC) after puberty due to hormonal changes. However, active treatment is essential in the meantime to prevent permanent vision damage, such as corneal scarring or keratoconus, from chronic inflammation and eye rubbing.
In this answer
3 sections
Yes, in the vast majority of cases, vernal keratoconjunctivitis (VKC) goes away after puberty. VKC is considered a chronic but self-limiting condition of childhood, meaning it typically resolves on its own as a child grows older [1][2]. While exact timelines vary from person to person, studies show that about 85% of children outgrow the condition by late adolescence or early adulthood, with most seeing complete resolution within 10 years of their initial diagnosis [2][3]. However, even though the disease will usually run its course eventually, it is critical to proactively manage and treat the condition in the meantime to prevent permanent damage to your child’s vision [4][5].
Why Does VKC Improve After Puberty?
The exact reasons why VKC resolves around puberty are not entirely understood, but researchers believe the body’s shifting endocrine system plays a major role [6]. The decrease in disease prevalence and severity after puberty strongly suggests that the hormonal changes associated with sexual maturation regulate the immune system’s response [7]. Essentially, as hormone levels change during adolescence, the intense allergic and inflammatory reactions that drive VKC tend to calm down [7].
Why You Cannot Just “Wait It Out”
Knowing that VKC will likely disappear in a few years can be reassuring, but it does not mean you can leave the condition untreated. Left unmanaged, the intense, chronic inflammation and the mechanical friction from chronic eye rubbing can cause severe, irreversible complications before the disease naturally resolves [4][8][9].
If VKC is not properly controlled, your child is at risk for:
- Shield ulcers: Painful, open sores on the clear front surface of the eye (cornea) caused by severe inflammation and friction [5][10].
- Corneal scarring: Permanent cloudy spots on the cornea that can permanently blur vision [4][11].
- Keratoconus: A condition where the cornea thins and bulges outward into a cone shape, heavily driven by intense, frequent eye rubbing in response to the severe itching of VKC [12][8].
Because of these risks, which can affect up to 30% of patients [13][4], active treatment is essential. Doctors often use topical immunomodulators (such as tacrolimus or cyclosporine), which are steroid-sparing eye drops that safely calm the immune system long-term [14][15]. This prevents the structural damage of VKC without relying on long-term steroid use, which carries its own risks of elevated eye pressure and steroid-induced glaucoma [16][17].
Factors That Might Delay Resolution
While most children outgrow VKC, a few factors can influence how long the condition lasts:
- Other allergic conditions: Children who also have severe atopic dermatitis (eczema) or asthma tend to have a lower chance of spontaneous resolution by puberty and may experience a longer course of the disease [3][18].
- Adult-onset VKC: In rare cases, VKC can persist into adulthood, or even appear for the first time in adults. However, adult-onset VKC usually follows a milder course than the childhood version [19][1].
- Climate and Environment: Living in warm, dry, or highly humid climates with high airborne allergen loads can make the disease more severe and potentially influence how long symptoms persist [20][21].
Common questions in this guide
Will my child eventually outgrow VKC?
Can we just wait for VKC to go away on its own without treatment?
What factors might make VKC last longer?
How is VKC treated while we wait for it to resolve?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my child's current age and symptoms, what timeline should we anticipate for their VKC resolving?
- 2.Are we doing enough to proactively control the inflammation and prevent structural damage to the cornea while we wait for them to outgrow it?
- 3.Has my child been screened for keratoconus using corneal topography, especially given how much they rub their eyes?
- 4.Can we discuss transitioning to a steroid-sparing agent like cyclosporine or tacrolimus to safely manage symptoms long-term?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (21)
- 1
[Vernal keratoconjunctivitis].
Mortemousque B
La Revue du praticien 2020; (70(7)):769-772.
PMID: 33739725 - 2
Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management.
Di Zazzo A, Zhu AY, Nischal K, Fung SSM
Frontiers in ophthalmology 2024; (4()):1328953 doi:10.3389/fopht.2024.1328953.
PMID: 38984145 - 3
Long-Term Observation of Prognostic Factors and Clinical Outcome of Vernal Keratoconjunctivitis in Childhood.
Shimokawa A, Ikeda A, Harada K, et al.
Clinical ophthalmology (Auckland, N.Z.) 2024; (18()):2339-2347 doi:10.2147/OPTH.S472826.
PMID: 39193318 - 4
Vernal keratoconjunctivitis and keratoconus.
Wajnsztajn D, Solomon A
Current opinion in allergy and clinical immunology 2021; (21(5)):507-514 doi:10.1097/ACI.0000000000000765.
PMID: 34269743 - 5
Surgical debridement of corneal shield ulcers in pediatric patients: two case reports and a review of the literature.
Stock RA, Lazzari SLT, Martins IP, Bonamigo EL
Journal of medical case reports 2020; (14(1)):70 doi:10.1186/s13256-020-02407-8.
PMID: 32546209 - 6
Understanding Vernal Keratoconjunctivitis: Beyond Allergic Mechanisms.
Sacchetti M, Plateroti R, Bruscolini A, et al.
Life (Basel, Switzerland) 2021; (11(10)) doi:10.3390/life11101012.
PMID: 34685384 - 7
Adult vernal keratoconjunctivitis.
Di Zazzo A, Bonini S, Fernandes M
Current opinion in allergy and clinical immunology 2020; (20(5)):501-506 doi:10.1097/ACI.0000000000000672.
PMID: 32675480 - 8
Risk Factors Associated with Keratoconus in an Iranian Population.
Mohammad-Rabei H, Ramin S, Lotfi S, et al.
Journal of ophthalmic & vision research 2023; (18(1)):15-23 doi:10.18502/jovr.v18i1.12721.
PMID: 36937196 - 9
An evaluation of corneal topographic changes in a large series of patients with vernal keratoconjunctivitis.
Reyhan AH, Bilak Ş
Journal francais d'ophtalmologie 2025; (48(3)):104404 doi:10.1016/j.jfo.2024.104404.
PMID: 39706131 - 10
Novel Insights in the Management of Vernal Keratoconjunctivitis (VKC): European Expert Consensus Using a Modified Nominal Group Technique.
Dahlmann-Noor A, Bonini S, Bremond-Gignac D, et al.
Ophthalmology and therapy 2023; (12(2)):1207-1222 doi:10.1007/s40123-023-00665-5.
PMID: 36790673 - 11
Does Mucous Membrane Grafting Have a Clear Advantage Over Amniotic Membrane Grafting in Refractory Giant Papillae?
Christy JS, Mouttapa F, Rajkumar P
Cornea 2018; (37(8)):e39 doi:10.1097/ICO.0000000000001611.
PMID: 29746328 - 12
Corneal topometric indices and proclivity toward corneal ectasia in vernal keratoconjunctivitis.
Yilmaz YC, Ipek SC, Gobeka HH
Journal francais d'ophtalmologie 2024; (47(1)):103792 doi:10.1016/j.jfo.2023.01.010.
PMID: 37087321 - 13
Vernal Keratoconjunctivitis in Kashmir: A temperate zone.
Sofi RA, Mufti A
International ophthalmology 2016; (36(6)):875-879 doi:10.1007/s10792-016-0213-8.
PMID: 26961753 - 14
Long-term use of topical tacrolimus ointment: a safe and effective option for the treatment of vernal keratoconjunctivitis.
Müller GG, José NK, de Castro RS, de Holanda EC
Arquivos brasileiros de oftalmologia 2019; (82(2)):119-123 doi:10.5935/0004-2749.20190026.
PMID: 30698232 - 15
Long-Term Clinical Outcome of Tacrolimus Skin Ointment (0.03%) for the Treatment of Vernal Keratoconjunctivitis: A Quasi-Experimental Study.
Ali W, Alam Khan S, Ullah Khan F, et al.
Cureus 2023; (15(12)):e50579 doi:10.7759/cureus.50579.
PMID: 38226116 - 16
Case series of children with steroid-Induced glaucoma.
Lam CS, Umi Kalthum MN, Norshamsiah MD, Bastion M
Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia 2018; (13(3)):32-37.
PMID: 30800232 - 17
Pattern of steroid misuse in vernal keratoconjunctivitis resulting in steroid induced glaucoma and visual disability in Indian rural population: An important public health problem in pediatric age group.
Sen P, Jain S, Mohan A, et al.
Indian journal of ophthalmology 2019; (67(10)):1650-1655 doi:10.4103/ijo.IJO_2143_18.
PMID: 31546501 - 18
Impression Cytology Screening for Ocular Surface changes in various forms of Vernal Keratoconjunctivitis in Subtropical Central Zone in India.
Thatte S, Varma A, Kapadia S, et al.
Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 2021; (13(24)):105-117 doi:10.3126/nepjoph.v13i2.32838.
PMID: 35996777 - 19
Unpacking VKC: How gender and age shape the clinical picture.
Chauhan G, Mathimaaran S, Chandrasekar A, et al.
Indian journal of ophthalmology 2025; (73(4)):594-598 doi:10.4103/IJO.IJO_177_25.
PMID: 40146146 - 20
Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East.
Fiorentini SF, Khurram D
Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2019; (33(2)):117-120 doi:10.1016/j.sjopt.2019.04.001.
PMID: 31384152 - 21
Demographic and clinical characteristics of childhood and adult onset Vernal Keratoconjunctivitis in a tertiary care center during Covid pandemic: A prospective study.
Singh A, Rana J, Kataria S, et al.
Romanian journal of ophthalmology 2022; (66(4)):344-351 doi:10.22336/rjo.2022.61.
PMID: 36589333
This page provides informational content about the natural progression of VKC. Always consult your child's eye doctor or pediatrician to properly manage symptoms and prevent permanent vision damage.
Get notified when new evidence is published on Vernal keratoconjunctivitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.